References
- François J, Collery AS, Hayek G, et al. Coronavirus disease 2019–associated ocular neuropathy with panuveitis: a case report. JAMA Ophthalmol. 2021;139(2):247–249. Published online December 17, 2020. doi:https://doi.org/10.1001/jamaophthalmol.2020.5695.
- Benito-Pascual B, Gegúndez JA, Díaz-Valle D, et al. Panuveitis and optic neuritis as a possible initial presentation of the novel coronavirus disease 2019 (COVID-19). Ocul Immunol Inflamm. 2020;28(6):922–925.doi:https://doi.org/10.1080/09273948.2020.1792512.
- Virgo J, Mohamed M. Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection. Eye. 1–2. Published online July 3, 2020. doi:https://doi.org/10.1038/s41433-020-1069-8 .
- Agarwal M, Dutta Majumder P, Babu K, et al. Drug-induced uveitis: a review. Indian J Ophthalmol. 2020;68(9):1799–1807. doi:https://doi.org/10.4103/ijo.IJO_816_20.
- Vounotrypidis P. COVID-19: an archetype innate immunity reaction and modes of treatment. Mediterr J Rheumatol. 2020;31(Suppl 2):275–283. doi:https://doi.org/10.31138/mjr.31.3.275.